Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts

Author:

Ball Claudia R1,Oppel Felix1,Ehrenberg Karl Roland12,Dubash Taronish D1,Dieter Sebastian M13,Hoffmann Christopher M1,Abel Ulrich1,Herbst Friederike1,Koch Moritz45,Werner Jens46,Bergmann Frank7,Ishaque Naveed89,Schmidt Manfred13,Kalle Christof13,Scholl Claudia1,Fröhling Stefan1310,Brors Benedikt8,Weichert Wilko37,Weitz Jürgen45,Glimm Hanno13ORCID

Affiliation:

1. Department of Translational Oncology National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ) Heidelberg Germany

2. Department of Medical Oncology National Center for Tumor Diseases (NCT) Heidelberg Germany

3. German Cancer Consortium (DKTK) University of Heidelberg Heidelberg Germany

4. Department of General Surgery University of Heidelberg Heidelberg Germany

5. Department of Visceral Thoracic and Vascular Surgery University Hospital Dresden Dresden Germany

6. Department of Surgery University of Munich Munich Germany

7. Institute of Pathology University Hospital Heidelberg Heidelberg Germany

8. Division of Theoretical Bioinformatics German Cancer Research Center (DKFZ) Heidelberg Germany

9. Heidelberg Center for Personalized Oncology DKFZ‐HIPO, DKFZ Heidelberg Germany

10. Heidelberg University Hospital Heidelberg Germany

Funder

Deutsches Krebsforschungszentrum

Deutsche Krebshilfe

Horizon 2020 Framework Programme

Deutsche Forschungsgemeinschaft

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3